治疗用药组(T-LBM)（略）。其中预防用药组又分三小组即罗布麻叶总黄酮低剂量组(P-LBM-L)、罗布麻叶总黄酮高剂量组(P-LBM-H)以及单纯给予维生素C的阳...
基于16个网页-相关网页
这项研究还发现，没有服用药片的病人中，62%有头疼症状，与之相比，得到治疗的其他三组中，只有不到50%的病人有头疼症状。
The study also found 62% of patients who didn't receive pills reported headaches compared with less than 50% of patients in the other three treatment groups.
经过26周的治疗，联合用药的病人中有57%获得缓解，与之相比，在单用英夫利昔单抗组中只有44%而单用硫唑嘌呤组中只有30%得到缓解。
After 26 weeks of treatment, patients getting the combination had a 57% chance of disease remission, compared to 44% of those getting Remicade alone and to 30% of those getting azathioprine alone.
结果：联合用药的两组与甘利欣单独治疗组比较均出现显著性差异。
Results Two groups of united medication compare with group of sole medication. it presented striking difference.
应用推荐